NetworkNewsBreaks

TuesdayOct 18, 2022 1:54 pm

NetworkNewsBreaks – Cyclyx International LLC. Collaborates to Advance Unique Houston-Based Plastic Processing Facility

Cyclyx International, together with ExxonMobil Corporation (NYSE: XOM) and LyondellBasell Industries (NYSE: LYB), today announced an agreement to advance development of a first-of-its-kind plastic waste sorting and processing facility in the Houston area. According to the update, the new facility addresses a critical missing link in the plastic waste supply chain by connecting community recycling programs to new and more advanced recycling technologies with the potential to take a much wider variety of plastic materials. The Cyclyx Circularity Center will be unique among plastic recovery facilities, leveraging new technologies to analyze and sort plastics based on their composition and best…

Continue Reading

TuesdayOct 18, 2022 1:37 pm

NetworkNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q3 2022 Results, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the close of the market on Tuesday, Nov. 8, 2022. In addition, Cepton will hold a conference call and webcast at 2:30 p.m. PT (5:30 p.m. ET) that same day. Interested parties may join the call by dialing 888-999-6281 and visiting https://nnw.fm/dk64g for the live webcast. A replay will be available approximately two hours after the live call and until Nov. 22, 2022, and can be…

Continue Reading

TuesdayOct 18, 2022 1:02 pm

NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University to Extend Research Pact

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines certain assets that are currently under development regarding the work of associate professor of clinical Neurobiology Dr. Christine Ann Denny at Columbia University Irving Medical Center. Denny and her team are studying the molecular mechanisms underlying learning and memory, including diseases such as Alzheimer’s disease. According to the announcement, Denny’s pioneering research is evaluating whether ketamine and novel inventions associated with the substance have potential…

Continue Reading

TuesdayOct 18, 2022 12:43 pm

NetworkNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports Assay Results from Iska Iska Drills

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has been conducting an ongoing drilling program at its Iska Iska silver-tin polymetallic project and is reporting on two diamond drill holes. According to the announcement, drill hole DSB-36 collared 400m southeast of the Santa Barbara adit, tested the extension of the core of the high-grade feeder zone at Santa Barbara while hole DSB-34 tested the potential southwest limits of the high-grade feeder zone. Eloro noted that so far 118 drill holes have…

Continue Reading

TuesdayOct 18, 2022 12:34 pm

NetworkNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Joins Hercules Electric Mobility CEO to Discuss New Deal

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, has signed an agreement with Hercules Electric Mobility to bring customizable electric mobility products to market. Leaders from the two companies — HLRTF CEO Don Currie and Hercules Electric Mobility CEO James Breyer — discussed the partnership on a recent Proactive interview with host Steve Darling, noting that the partnership is aimed at integrating the latest technologies into new, innovative products and accelerating the path to market. To view the full interview, visit https://nnw.fm/9RCPx To view…

Continue Reading

MondayOct 17, 2022 2:35 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for what it called ‘the first and only’ 3D-vector, 12-lead ECG platform for heart attack detection, this in conjunction with a credit card-sized device inside a consumer’s wallet for personal monitoring,” the piece reads. “The company said it can record and remotely transmit a set of cardiac signals to a physician for review so that patients at high risk of cardiac arrest are not left alone…

Continue Reading

MondayOct 17, 2022 1:38 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog to enter clinical development. “The in-human trial is critical to the company’s continued development of CYB003, a deuterated psilocybin analog that Cybin believes has potential to successfully address the challenges and limitations of oral psilocybin. According to the company’s preclinical research, CYB003 achieved less variability in plasma levels, along with faster onset of action, improved brain penetration, and shorter duration…

Continue Reading

MondayOct 17, 2022 1:07 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Anticipating 2023 IND Application for Secondary Portfolio Candidate

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans to test the effectiveness of its anti-glioblastoma (“GBM”) drug candidate – Berubicin. Testing of Berubicin resulted in a notable success with evidence of improved survival among a dozen safety trial participants recruited by the drug’s original developer over 15 years ago. In its annual stockholder meeting, the company also provided an update for its secondary drug portfolio WP1244. The anthracycline-based substance, being evaluated for the treatment of brain cancers, ovarian and lymphomas, “has produced a new derivative as WP1874 with…

Continue Reading

MondayOct 17, 2022 12:55 pm

NetworkNewsBreaks – Odyssey Health Inc.’s (ODYY) PRV-002 Designed to Mitigate Short- and Long-Term Effects of mTBI

Odyssey Health (OTC: ODYY) early last year acquired PRV-002, a drug candidate for concussed patients to mitigate both short-term and long-term consequences of concussion. Concussion or mTBI “is caused by a jolt, blow or force to the head that changes the brain’s function. This change often results in myriad consequences ranging from emotional and somatic changes to cognitive impairment and physical symptoms… In most cases, concussion symptoms resolve within a few days or weeks as the damaged pathways rebuild and strengthen through repetition, use and cleanup of cell debris. However, there has been growing concern that mTBI may be associated…

Continue Reading

MondayOct 17, 2022 12:48 pm

NetworkNewsBreaks – Stronghold Digital Mining Inc. (NASDAQ: SDIG) Announces Significant Progress to Deliver Shareholder Value

Stronghold (NASDAQ: SDIG) on Friday provided an update on its previously announced agreement with NYDIG ABL LLC (“NYDIG”) and the Provident Bank (“BankProv”), to eliminate approximately $67 million in principal amount of debt outstanding under equipment financing agreements. Separately, Stronghold also announced its recent mutual termination and settlement of its data center hosting agreement. “We are pleased to have closed on a significant portion of our debt restructuring with NYDIG and look forward to eliminating the small remaining piece of this debt in the near future. These closings continue our meaningful transition towards a deleveraged company that can either sell…

Continue Reading